August 2026
The regulation of assisted reproductive technology (ART) is no longer evolving in isolation. In recent months, governments on opposite sides of the world have introduced major legislative reforms aimed at modernising fertility treatment, donor conception and patient protections.
In Ecuador, lawmakers are debating the country’s first comprehensive Assisted Reproduction Law.
Meanwhile, in Queensland, Australia, a completely new regulatory framework for assisted reproductive technology has begun coming into force, introducing state licensing, a donor conception information register and strengthened oversight of fertility clinics.
Although the two countries have very different healthcare and regulatory systems, they are addressing many of the same questions:
• How should donor conception be regulated?
• What rights should donor-conceived people have?
• How should fertility clinics be supervised?
• How should governments balance patient access with ethical safeguards?
• What information should be preserved for future donor conceived generations?
Together, these reforms demonstrate that assisted reproduction has become not only a medical issue but increasingly a public policy priority.
Ecuador: Establishing its first ART law
Ecuador has never previously had dedicated legislation governing IVF, sperm donation, egg donation and embryo management.
The proposed law would establish a national framework regulating:
• IVF and other ART procedures
• fertility clinics
• sperm, egg and embryo banks
• donor eligibility
• informed consent
• embryo management
• legal parentage based on “procreative intent”
• national oversight of fertility services.
The legislation follows years of legal uncertainty and constitutional rulings highlighting the need for clearer protection of families created through assisted reproduction.
Australia: Moving from professional self-regulation to government oversight
Queensland’s new Assisted Reproductive Technology Act represents one of Australia’s most significant fertility reforms in recent years.
The legislation introduces:
• mandatory licensing of ART providers
• government regulation of fertility clinics
• mandatory reporting of adverse events
• strengthened consent requirements
• enhanced counselling requirements
• detailed record keeping
• investigations and enforcement powers
• a statewide Donor Conception Information Register.
Rather than relying primarily on professional accreditation, Queensland Health becomes the statutory regulator overseeing fertility providers.
Donor conception is becoming central to regulation
An interesting similarity between the Ecuadorian and Australian reforms is the growing emphasis on donor conception. Historically, legislation focused primarily on clinical standards. Today, policymakers increasingly recognise that donor conception involves lifelong interests extending well beyond fertility treatment itself.
Queensland’s legislation establishes a donor conception information register that will allow eligible donor-conceived people, donors and recipient parents to access information under a staged implementation beginning in 2026.
Ecuador’s proposal similarly introduces national record keeping, regulation of gamete donation and legal recognition of intended parenthood.
Although the two models differ, both acknowledge that donor conception requires robust governance and long-term transparency.
Protecting future generations
Another common theme is that regulation increasingly considers not only today’s patients in the intended parents, but also tomorrow’s adults.
Modern legislation is placing greater emphasis on:
• preserving donor records
• counselling before treatment
• informed consent
• medical traceability
• safeguarding donor-conceived people’s interests
• long-term storage of reproductive information.
Queensland’s legislation specifically aims to protect the welfare and interests of ART users, donors and donor-conceived people while improving public confidence in fertility services.
Different countries with similar questions
Despite very different political environments, governments around the world are debating remarkably similar issues including:
Who should be eligible for treatment?
Questions concerning single women, same-sex couples and intended parents continue to evolve worldwide.
Should donor identities remain anonymous?
Many countries are moving towards greater transparency for donor-conceived individuals.
Others continue to prioritise donor confidentiality.
How many families should one donor help create?
Family limits remain one of the most debated regulatory questions internationally.
Should fertility treatment receive public funding?
Countries differ substantially regarding insurance coverage and public reimbursement.
Who regulates fertility clinics?
Independent accreditation is increasingly being complemented or replaced by direct governmental oversight.
The global trend
Recent developments illustrate that Ecuador and Australia are far from unique. During the past year alone we have also seen important fertility policy discussions in:
• United States – proposed employer-based fertility benefit reforms;
• Ireland – amendments concerning assisted reproduction and legal parenthood;
• Switzerland – ongoing debate regarding restrictions on egg donation and access;
• European Union – implementation of the new SoHO Regulation strengthening quality, safety and traceability standards.
Although each country takes a different approach, the direction is clear. Regulation is becoming increasingly sophisticated, recognising that assisted reproduction encompasses medicine, ethics, law, genetics, identity and human rights.
Our perspective
The rapid pace of regulatory reform demonstrates that assisted reproduction has become a global policy issue.
For patients, this means greater legal certainty but also increasing complexity when comparing treatment options across countries.
For fertility clinics and gamete banks, it highlights the growing importance of compliance, quality management and transparent donor governance.
For donor-conceived people, it reflects a broader international movement towards recognising their lifelong interests alongside those of intended parents and donors.
As international fertility treatment and cross-border reproductive care continue to grow, national legislation can no longer be viewed in isolation. The future of assisted reproduction will increasingly depend on how countries learn from one another while balancing innovation, patient access, ethical principles and the rights of future generations.
